Trade Stoke Therapeutics, Inc. - STOK CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.15
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.02154 %(-$0.43)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.02154%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000682 %(-$0.01)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.00068%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.02154 %
  (-$0.43)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000682 %
  (-$0.01)

Key Stats

• Prev. Close: 31.88
• Open: 31.34
• 1-Year Change: 142.57%
• Day's Range: 31.34 - 32.91

Trade Stoke Therapeutics, Inc. - STOK

What is Stoke Therapeutics, Inc. (STOK)?

Stoke Therapeutics, Inc. is a biotechnology company focused on the development of genetic medicines to treat rare neurological diseases. The company employs a proprietary antisense oligonucleotide platform designed to upregulate gene expression and restore protein levels in patients with genetic disorders. Stoke Therapeutics targets conditions caused by insufficient protein production due to genetic mutations. Its research and development efforts aim to create therapies that address the underlying causes of diseases rather than only managing symptoms. The company collaborates with academic institutions and industry partners to advance its pipeline of therapeutic candidates. Stoke Therapeutics operates within the broader biotechnology sector, concentrating on innovative approaches to treat diseases with significant unmet medical needs. Its work contributes to the expanding field of precision medicine and genetic therapies.

Stoke Therapeutics, Inc. Stock Price Today: Live Overview

The price today is shaped by the current trading session, as Stoke Therapeutics, Inc. trades at $31.96. The intraday range spans from $31.33 to $32.91, with a daily percentage change of -0.0943%.

FAQ: Stoke Therapeutics, Inc. (STOK)

What is the current price of STOK stock?

The current trading price is $31.96.

Does STOK pay dividends?

Stoke Therapeutics, Inc. does not currently pay dividends.

Does STOK have a formal corporate presence or regional headquarters in the UAE?

Stoke Therapeutics, Inc. operates via partners and distributors in the UAE without an official regional office or subsidiary.

What is STOK best known for?

Stoke Therapeutics, Inc. is most famous for its development of RNA-based therapeutics targeting genetic diseases.

What assets are typically shown together with STOK?

Commonly shown alongside STOK: SPDR S&P U.S. Consumer Staples Select Sector UCITS ETF, Naturgy Energy Group, S.A., CytomX Therapeutics Inc